Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

Market Cap	5.34B -33.1%
Revenue (ttm)	3.01B -0.8%
Net Income	403.78M -21.2%
EPS	0.81 -21.9%
Shares Out	494.11M
PE Ratio	13.41
Forward PE	7.35
Dividend	0.40 (3.74%)
Ex-Dividend Date	May 28, 2026

Volume	4,972,795
Open	10.61
Previous Close	10.69
Day's Range	10.47 - 10.81
52-Week Range	10.48 - 20.66
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and br...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,298
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300705

Financial Performance

In 2025, SHE:300705's revenue was 3.11 billion, an increase of 6.15% compared to the previous year's 2.93 billion. Earnings were 472.82 million, a decrease of -7.72%.